'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

Price controls are bad for Israel
24/05/2022
Haaretz cartoon
24/05/2022
Israel is marching eyes wide open into another war with Hamas
24/05/2022
Assassinated Iranian colonel was behind attack on Israeli diplomat in India, report says
23/05/2022
Bank of Israel raises interest rate to 0.75 percent, higher than expected
23/05/2022
Minister allows Ukrainian war refugees to legally work in Israel
23/05/2022